Deciphera Pharmaceuticals, Inc. Deferred Offering Costs
Deciphera Pharmaceuticals, Inc. had Deferred Offering Costs of $0 as of 2017-12-31, per its 10-K filed 2018-03-28.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2018-03-28
- 2017-12-31: Deferred Offering Costs $0.00.
- 2016-12-31: Deferred Offering Costs $104.00K.
| Period end | Deferred Offering Costs |
|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-28 |
| 2016-12-31 | $104.00K 10-K · filed 2018-03-28 |